Replies to post #437 on Cynapsus Therapeutics Inc. (CYNA)

[noretreat]

I agree. In addition, the time line suggests that the strip will be ready for an NDA about a year earlier than the inhaler. At this point the inhaler still requires pre-mixing as well, making it quite a bit more difficult to use.

I had a good conversation with Cynapsus management last week and remain optimistic about the company. They could move a bit faster, of course, and their view of the competitive situation may be a bit optimistic.

[Seel]

That is an excellent way to describe this drug. Great comparison example. CYNAF one of the surer bets in this risky sector.